Stock Quote Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Markets Stocks ETFs Tools Overview News Currencies International Treasuries Alx Oncology Holdings Inc (NQ: ALXO ) 15.14 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Aug 15, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 15.14 Bid (Size) 14.70 (3) Ask (Size) 17.00 (2) Prev. Close 15.14 Today's Range 15.14 - 15.14 52wk Range 5.820 - 81.19 Shares Outstanding 40,747,065 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year Top News More News Recap Of Thursday's Biotech Catalysts - End Of the Day Summary August 11, 2022 Via Benzinga ALX Oncology Shares Climb As Mid-Stage Triple Combination Colorectal Cancer Study Kicks-off August 11, 2022 ALX Oncology Holdings (NASDAQ: ALXO) has initiated a Phase 2 investigator-sponsored study of evorpacept in combination with Eli Lilly’s (NYSE: LLY) ERBITUX (cetuximab) and Merck’s (NASDAQ: Via Benzinga Performance YTD -31.37% -31.37% 1 Month +46.00% +46.00% 3 Month +58.04% +58.04% 6 Month +1.14% +1.14% 1 Year -77.08% -77.08% More News Read More Recap Of Monday's Biotech Catalysts - End Of the Day Summary August 01, 2022 Via Benzinga Daily Biotech Pulse: Celyad Resumes Colorectal Cancer Trial, Setback For Otonomy, AstraZeneca Halts Phase 3 Head, Neck Cancer Trial August 01, 2022 Via Benzinga ALX Oncology's Evorpacept Gets Orphan Drug Tag For Gastric Cancer January 28, 2022 Via Benzinga ALX Oncology Shares Gain As FDA Grants Fast Track Status To Head And Neck Cancer Candidate August 01, 2022 Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session July 12, 2022 Via Benzinga The Daily Biotech Pulse: Eli Lilly Modifies COVID-19 Treatment Pact, Oyster Point Outlines Restructuring Plan, Icosavax Posts Interim RSV Vaccine Data June 29, 2022 Via Benzinga ALX Oncology Shares Soar As FDA Grants Orphan Drug Status To Blood Cancer Candidate June 29, 2022 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session June 29, 2022 Via Benzinga Stocks That Hit 52-Week Lows On Monday June 06, 2022 Via Benzinga Stocks That Hit 52-Week Lows On Tuesday May 31, 2022 Via Benzinga ALX Oncology Holdings: Q4 Earnings Insights February 28, 2022 Via Benzinga The Daily Biotech Pulse: Biogen Liquidates Out Of Biosimilar JV, Provention Bio Plots Diabetes Drug Resubmission, Merck Finds COVID Pill Effective Against Omicron January 28, 2022 Via Benzinga Stocks That Hit 52-Week Lows On Wednesday January 26, 2022 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session January 26, 2022 Via Benzinga Gastrointestinal Cancer Treatment Trials Driven by Rising Incidences of Colorectal Cancer January 20, 2022 Via FinancialNewsMedia Topics Death Exposures Death Benzinga's Top Ratings Upgrades, Downgrades For December 22, 2021 December 22, 2021 Via Benzinga 10 Biggest Price Target Changes For Wednesday December 22, 2021 Via Benzinga ALX Oncology's Evorpacept Data Fails To Impress At ASH Presentation December 13, 2021 Via Benzinga 58 Biggest Movers From Yesterday December 14, 2021 Via Benzinga 40 Stocks Moving In Monday's Mid-Day Session December 13, 2021 Via Benzinga 75 Biggest Movers From Yesterday November 10, 2021 Via Benzinga ALX Oncology Falls After Updated Data For Solid Tumors Candidate November 09, 2021 Via Benzinga 58 Stocks Moving In Monday's Mid-Day Session November 09, 2021 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
